Copyright Reports & Markets. All rights reserved.

Global Melanoma Therapeutics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Melanoma Therapeutics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Melanoma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Chemotherapy
    • 1.4.3 Immunotherapy
    • 1.4.4 Targeted Therapy
    • 1.4.5 Radiation Therapy
  • 1.5 Market by Application
    • 1.5.1 Global Melanoma Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Opdivo
    • 1.5.3 Yervoy
    • 1.5.4 Mekinist+Tafinlar
    • 1.5.5 Keytruda
    • 1.5.6 Cotellic
    • 1.5.7 Zelboraf
    • 1.5.8 Imlygic
    • 1.5.9 Generics
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Melanoma Therapeutics Market Perspective (2015-2026)
  • 2.2 Global Melanoma Therapeutics Growth Trends by Regions
    • 2.2.1 Melanoma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Melanoma Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Melanoma Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Melanoma Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Melanoma Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Melanoma Therapeutics Players by Market Size
    • 3.1.1 Global Top Melanoma Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Melanoma Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Melanoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Melanoma Therapeutics Market Concentration Ratio
    • 3.2.1 Global Melanoma Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Melanoma Therapeutics Revenue in 2019
  • 3.3 Melanoma Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Melanoma Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Melanoma Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Melanoma Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Melanoma Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Melanoma Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Melanoma Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Melanoma Therapeutics Market Size (2015-2020)
  • 6.2 Melanoma Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Melanoma Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Melanoma Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Melanoma Therapeutics Market Size (2015-2020)
  • 7.2 Melanoma Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Melanoma Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Melanoma Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Melanoma Therapeutics Market Size (2015-2020)
  • 8.2 Melanoma Therapeutics Key Players in China (2019-2020)
  • 8.3 China Melanoma Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Melanoma Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Melanoma Therapeutics Market Size (2015-2020)
  • 9.2 Melanoma Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Melanoma Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Melanoma Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Melanoma Therapeutics Market Size (2015-2020)
  • 10.2 Melanoma Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Melanoma Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Melanoma Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Melanoma Therapeutics Market Size (2015-2020)
  • 11.2 Melanoma Therapeutics Key Players in India (2019-2020)
  • 11.3 India Melanoma Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Melanoma Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Melanoma Therapeutics Market Size (2015-2020)
  • 12.2 Melanoma Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Melanoma Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Melanoma Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 AstraZeneca
    • 13.1.1 AstraZeneca Company Details
    • 13.1.2 AstraZeneca Business Overview
    • 13.1.3 AstraZeneca Melanoma Therapeutics Introduction
    • 13.1.4 AstraZeneca Revenue in Melanoma Therapeutics Business (2015-2020))
    • 13.1.5 AstraZeneca Recent Development
  • 13.2 Amgen, Inc.
    • 13.2.1 Amgen, Inc. Company Details
    • 13.2.2 Amgen, Inc. Business Overview
    • 13.2.3 Amgen, Inc. Melanoma Therapeutics Introduction
    • 13.2.4 Amgen, Inc. Revenue in Melanoma Therapeutics Business (2015-2020)
    • 13.2.5 Amgen, Inc. Recent Development
  • 13.3 F. Hoffmann-La Roche Ltd.
    • 13.3.1 F. Hoffmann-La Roche Ltd. Company Details
    • 13.3.2 F. Hoffmann-La Roche Ltd. Business Overview
    • 13.3.3 F. Hoffmann-La Roche Ltd. Melanoma Therapeutics Introduction
    • 13.3.4 F. Hoffmann-La Roche Ltd. Revenue in Melanoma Therapeutics Business (2015-2020)
    • 13.3.5 F. Hoffmann-La Roche Ltd. Recent Development
  • 13.4 Bristol-Myers Squibb Company
    • 13.4.1 Bristol-Myers Squibb Company Company Details
    • 13.4.2 Bristol-Myers Squibb Company Business Overview
    • 13.4.3 Bristol-Myers Squibb Company Melanoma Therapeutics Introduction
    • 13.4.4 Bristol-Myers Squibb Company Revenue in Melanoma Therapeutics Business (2015-2020)
    • 13.4.5 Bristol-Myers Squibb Company Recent Development
  • 13.5 Novartis AG
    • 13.5.1 Novartis AG Company Details
    • 13.5.2 Novartis AG Business Overview
    • 13.5.3 Novartis AG Melanoma Therapeutics Introduction
    • 13.5.4 Novartis AG Revenue in Melanoma Therapeutics Business (2015-2020)
    • 13.5.5 Novartis AG Recent Development
  • 13.6 Merck & Co., Inc.
    • 13.6.1 Merck & Co., Inc. Company Details
    • 13.6.2 Merck & Co., Inc. Business Overview
    • 13.6.3 Merck & Co., Inc. Melanoma Therapeutics Introduction
    • 13.6.4 Merck & Co., Inc. Revenue in Melanoma Therapeutics Business (2015-2020)
    • 13.6.5 Merck & Co., Inc. Recent Development
  • 13.7 Daiichi Sankyo Company, Limited
    • 13.7.1 Daiichi Sankyo Company, Limited Company Details
    • 13.7.2 Daiichi Sankyo Company, Limited Business Overview
    • 13.7.3 Daiichi Sankyo Company, Limited Melanoma Therapeutics Introduction
    • 13.7.4 Daiichi Sankyo Company, Limited Revenue in Melanoma Therapeutics Business (2015-2020)
    • 13.7.5 Daiichi Sankyo Company, Limited Recent Development
  • 13.8 AB Sciences
    • 13.8.1 AB Sciences Company Details
    • 13.8.2 AB Sciences Business Overview
    • 13.8.3 AB Sciences Melanoma Therapeutics Introduction
    • 13.8.4 AB Sciences Revenue in Melanoma Therapeutics Business (2015-2020)
    • 13.8.5 AB Sciences Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Melanoma Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Melanoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    AstraZeneca
    Amgen, Inc.
    F. Hoffmann-La Roche Ltd.
    Bristol-Myers Squibb Company
    Novartis AG
    Merck & Co., Inc.
    Daiichi Sankyo Company, Limited
    AB Sciences

    Market segment by Type, the product can be split into
    Chemotherapy
    Immunotherapy
    Targeted Therapy
    Radiation Therapy
    Market segment by Application, split into
    Opdivo
    Yervoy
    Mekinist+Tafinlar
    Keytruda
    Cotellic
    Zelboraf
    Imlygic
    Generics

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now